80 related articles for article (PubMed ID: 400698)
1. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.
McElwain TJ; Hedley DW; Gordon MY; Jarman M; Millar JL; Pritchard J
Exp Hematol; 1979; 7 Suppl 5():360-71. PubMed ID: 400698
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.
Lazarus HM; Herzig RH; Wolff SN; Phillips GL; Spitzer TR; Fay JW; Herzig GP
Cancer Treat Rep; 1985 May; 69(5):473-7. PubMed ID: 3891085
[TBL] [Abstract][Full Text] [Related]
3. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
7. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
[TBL] [Abstract][Full Text] [Related]
9. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S
Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012
[TBL] [Abstract][Full Text] [Related]
10. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.
McElwain TJ; Hedley DW; Burton G; Clink HM; Gordon MY; Jarman M; Juttner CA; Millar JL; Milsted RA; Prentice G; Smith IE; Spence D; Woods M
Br J Cancer; 1979 Jul; 40(1):72-80. PubMed ID: 383125
[TBL] [Abstract][Full Text] [Related]
11. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D
Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced Hodgkin's disease with high dose melphalan and autologous bone marrow transplantation.
Russell JA; Selby PJ; Ruether BA; Mbidde EK; Ashley S; Zulian G; Berry J; Houwen B; Jones AR; Poon MC
Bone Marrow Transplant; 1989 Jul; 4(4):425-9. PubMed ID: 2673463
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Devereaux S; Linch DC; Gribben JG; McMillan A; Patterson K; Goldstone AH
Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
[TBL] [Abstract][Full Text] [Related]
15. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
[TBL] [Abstract][Full Text] [Related]
16. [Autologous bone marrow transplantation in pediatric cancer].
Ohira M
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
[TBL] [Abstract][Full Text] [Related]
17. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
Roodman GD; LeMaistre CF; Clark GM; Page CP; Newcomb TF; Knight WA
Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
[TBL] [Abstract][Full Text] [Related]
18. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in children with neuroblastoma.
Dopfer R; Berthold F; Einsele H; Ehninger G; Klingebiel T; Handgretinger R; Bruchelt G; Niethammer D; Stollmann B; Rister M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):427-36. PubMed ID: 2480285
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.
Vassal G; Tranchand B; Valteau-Couanet D; Mahé C; Couanet D; Schoeppfer C; Grill J; Kalifa C; Hill C; Ardiet C; Hartmann O
Bone Marrow Transplant; 2001 Mar; 27(5):471-7. PubMed ID: 11313680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
